HARVARD BIOSCIENCE INC
HBIOHarvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International (DSI), Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems (MCS), Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 10, 2026
6dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
HBIO Earnings Report
FQ end 2026-06
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is HARVARD BIOSCIENCE INC's next FDA catalyst?→
HARVARD BIOSCIENCE INC's (HBIO) next tracked catalyst is a Earnings expected August 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track HBIO biotech catalysts?→
Add HBIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow HARVARD BIOSCIENCE INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.